TOFACITINIB gene signatures (6)

All reports

Custom Report Builder

  1. Using the checkboxes in the right-most column, select gene signatures.
  2. Select at least 3 signatures.
  3. Name the report.
  4. (Optional) Select a metadata field upon which to categorize the signatures. The percentage indicates what percentage of gene signatures have values for that metadata field.
  5. Click Build report
Title Organism Platform Optional Metadata
1 Prevention of Mouse AA with IL-15 pathway ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib
Disease 13 weeks
2 Treatment of established mouse AA with topical ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib
Time 6 weeks
3 Treatment of established mouse AA with topical ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib
Time 12 weeks
4 Treatment of established mouse AA with topical ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib
Time 24 weeks
5 Topical protein tyrosine kinase inhibitor ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib 6 weeks
6 Topical protein tyrosine kinase inhibitor ... Mus musculus Mus musculus
Cell Skin
Perturbation Tofacitinib 12 weeks